SCHEMBL7303399

SCHEMBL7303399

CC1CCNC(C#N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL17473471 0.98 L3MBTL1 (0.35)
SCHEMBL27895274 0.77
SCHEMBL30016448 0.77
SCHEMBL27072050 0.77
SCHEMBL27056676 0.77
SCHEMBL16921050 0.76
SCHEMBL28452274 0.76
SCHEMBL16921038 0.76
SCHEMBL15492418 0.76
SCHEMBL19245100 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116478085-B Method for resolution synthesis of argatroban intermediate (2R, 4R) -4-methyl-2-ethyl piperidine formate 浙江康聚药业有限公司 2023-11-07 CN claimed
CN-116478085-A Method for resolution synthesis of argatroban intermediate (2R, 4R) -4-methyl-2-ethyl piperidine formate 浙江康聚药业有限公司 2023-07-25 CN claimed
CN-106699638-B Preparation method of argatroban intermediate 天津药物研究院药业有限责任公司 2019-06-25 CN claimed
CN-108047125-A The preparation method of one kind (2R, 4R) -4- methyl piperidine -2- Ethyl formate compounds 北京沃邦医药科技有限公司 2018-05-18 CN claimed
CN-118684618-A Argatroban middle Process for the preparation of intermediates 山东新时代药业有限公司 2024-09-24 CN disclosed
CN-116478085-B Method for resolution synthesis of argatroban intermediate (2R, 4R) -4-methyl-2-ethyl piperidine formate 浙江康聚药业有限公司 2023-11-07 CN disclosed
CN-116478085-A Method for resolution synthesis of argatroban intermediate (2R, 4R) -4-methyl-2-ethyl piperidine formate 浙江康聚药业有限公司 2023-07-25 CN disclosed
CN-116217466-A Preparation method of argatroban intermediate 4-methyl-2-ethyl piperidine formate 山东新时代药业有限公司 2023-06-06 CN disclosed
CN-109761886-B Resolution method of argatroban starting material isomer impurities 北京悦康科创医药科技股份有限公司 2020-09-11 CN disclosed
CN-109734653-B Resolution method of argatroban starting material isomer impurities 北京悦康科创医药科技股份有限公司 2020-07-14 CN disclosed
CN-109761885-B Resolution method of argatroban isomer impurities 北京悦康科创医药科技股份有限公司 2020-06-26 CN disclosed
US-10385020-B2 Process intermediates and methods for the preparation of process intermediates for the synthesis of argatroban monohydrate LUNDBECK PHARMACEUTICALS ITALY S.P.A. (IT) 2019-08-20 US disclosed
US-4131673-A INHIBITION AND SUPPRESSION OF THROMBOSIS IN MAMMALS MITSUBISHI CHEMICAL INDUSTRIES, LIMITED (JP) 1978-12-26 US disclosed
US-4117127-A INHIBITION AND SUPPRESSION OF THROMBOSIS MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) 1978-09-26 US disclosed
US-4101653-A ANTITHROMBOSIS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1978-07-18 US disclosed
US-4097472-A INHIBITION AND SUPRESSION OF THROMBOSIS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) 1978-06-27 US disclosed
US-4093712-A ANTITHROMBOGENIC AGENTS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) 1978-06-06 US disclosed
US-4073913-A INHIBITION AND SUPPRESSION OF THROMBIN MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) 1978-02-14 US disclosed
US-4072757-A SUPPRESSION OF THROMBOSIS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) 1978-02-07 US disclosed
US-4066773-A ANTITHROMBOSIS MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) 1978-01-03 US disclosed